SLE, An Overlooked Disease: Possibilities for Early Rescue by Early Diagnosis

@inproceedings{Arafa2018SLEAO,
  title={SLE, An Overlooked Disease: Possibilities for Early Rescue by Early Diagnosis},
  author={Reem Khidr Mohamed Arafa and M. M. Mohameed Ahmed},
  year={2018}
}
Systemic lupus erythematosus (SLE) is a progressive autoimmune disease associated with widespread organ damage that can eventually cause death. Worldwide prevalence of SLE is difficult to report mainly due to difficulty in diagnosis as a result of its heterogeneous nature and nonspecific protean manifestations. Currently, circulating anti-DNA antibodies are the most specific diagnostic biomarkers for SLE where many detection assays are being employed in clinical practice. However, the… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 134 REFERENCES

Antinuclear antibodies: diagnostic significance and methods.

  • Arthritis and rheumatism
  • 1967
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Antinuclear antibody testing — misunderstood or misbegotten?

  • Nature Reviews Rheumatology
  • 2017
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Standardization of anti-DNA antibody assays

  • Immunologic research
  • 2013
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Biomarkers for systemic lupus erythematosus.

  • International journal of rheumatic diseases
  • 2012
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Challenges of ethnicity in SLE.

  • Best practice & research. Clinical rheumatology
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Fritzler ML.Microbead-based technologies in diagnostic autoantibody detection

MJ Fritzler
  • Expert Opinion on Medical Diagnostics
  • 2009
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…